Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.
暂无分享,去创建一个
R. Weinberg | Y. Iwamoto | R. Kamm | Michelle B. Chen | M. Pittet | I. Zervantonakis | V. Cortez-Retamozo | E. Fessler | D. Raulet | M. Brooks | F. Reinhardt | Jordan A. Krall | A. Iannello | M. Ardolino | A. Spiegel | S. Houshyar | Jasmine DeCock | Asaf Spiegel | Ferenc Reinhardt
[1] Ronit Vogt Sionov,et al. The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment , 2015, Cancer Microenvironment.
[2] E. Passegué,et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils , 2015, Proceedings of the National Academy of Sciences.
[3] R. Hynes,et al. Platelets guide the formation of early metastatic niches , 2014, Proceedings of the National Academy of Sciences.
[4] C. Garlanda,et al. Tumor associated macrophages and neutrophils in cancer. , 2013, Immunobiology.
[5] Roger D Kamm,et al. Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[6] Richard O Hynes,et al. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. , 2012, Cancer discovery.
[7] A. Aguzzi,et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. , 2012, Cancer cell.
[8] R. Weinberg,et al. The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. , 2012, Cancer discovery.
[9] S. Albelda,et al. Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.
[10] G. Trinchieri. Cancer and inflammation: an old intuition with rapidly evolving new concepts. , 2012, Annual review of immunology.
[11] D. Gabrilovich,et al. Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.
[12] Daniel G. Anderson,et al. Origins of tumor-associated macrophages and neutrophils , 2012, Proceedings of the National Academy of Sciences.
[13] L. Norton,et al. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. , 2011, Cancer cell.
[14] G. Lesinski,et al. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. , 2011, Cancer research.
[15] Jinghang Zhang,et al. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.
[16] B. Roschitzki,et al. Abstract 5101: Biomarker identification in non-small cell lung cancer (NSCLC) with activity-based proteomics , 2011 .
[17] J. Joyce,et al. Proteolytic networks in cancer. , 2011, Trends in cell biology.
[18] G. Motohashi,et al. Evaluations of interferon‐γ/interleukin‐4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients , 2010, Journal of surgical oncology.
[19] J. D. Di Santo,et al. IL‐1β regulates a novel myeloid‐derived suppressor cell subset that impairs NK cell development and function , 2010, European journal of immunology.
[20] Thijs J. Hagenbeek,et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes , 2010, Proceedings of the National Academy of Sciences.
[21] E. Morii,et al. The first 2 cases of granulocyte colony-stimulating factor producing adenocarcinoma of the uterine cervix. , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[22] X. An,et al. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[23] H. Moses,et al. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. , 2010, Cancer research.
[24] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[25] Xiang Hu,et al. The Baseline Ratio of Neutrophils to Lymphocytes is Associated with Patient Prognosis in Rectal Carcinoma , 2010, Journal of gastrointestinal cancer.
[26] G. Cheng,et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.
[27] M. Manns,et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor , 2009, Hepatology.
[28] D. Kontoyiannis,et al. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients , 2009, Cancer.
[29] Xin Lu,et al. Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone* , 2009, The Journal of Biological Chemistry.
[30] M. Tsuboi,et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. , 2009, European journal of cancer.
[31] R. Weinberg,et al. Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs , 2009, Proceedings of the National Academy of Sciences.
[32] Y. Meng,et al. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models , 2009, Proceedings of the National Academy of Sciences.
[33] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[34] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[35] J. Erler,et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.
[36] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[37] J. Atzpodien,et al. Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma. , 2008, Cancer biotherapy & radiopharmaceuticals.
[38] Michael D. Connolly,et al. Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice , 2008, Journal of leukocyte biology.
[39] J. Quigley,et al. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis , 2007, Proceedings of the National Academy of Sciences.
[40] G. Fuh,et al. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells , 2007, Nature Biotechnology.
[41] J. Kappes,et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. , 2007, Blood.
[42] Yarong Wang,et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.
[43] Hiroyuki Aburatani,et al. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.
[44] Christopher Chiu,et al. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.
[45] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[46] K. Ley,et al. Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. , 2005, The Journal of clinical investigation.
[47] L. Lybarger,et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.
[48] R. Vance,et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.
[49] M. Luisa Iruela-Arispe,et al. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors , 2005, The Journal of cell biology.
[50] B. Fingleton,et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.
[51] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[52] M. Shibuya,et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.
[53] T. Kitamura,et al. Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein. , 2002, The Journal of urology.
[54] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[55] Constance E. Brinckerhoff,et al. Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.
[56] Nicholas R. English,et al. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.
[57] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[58] F. Bazzoni,et al. The neutrophil as a cellular source of chemokines , 2000, Immunological reviews.
[59] Mitsunari Yamamoto,et al. Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma , 1999, Journal of Gastroenterology.
[60] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[61] D. McEachern,et al. Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia. , 1992, British Journal of Cancer.
[62] F. Miller,et al. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.
[63] M. Kris,et al. Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer , 1991 .
[64] D. Welch,et al. Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[65] Craig W. Reynolds,et al. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. , 1983, Journal of immunology.
[66] T. Yoneda,et al. In vivo effect of anti-asialo GM1 antibody on natural killer activity , 1981, Nature.
[67] C. Riccardi,et al. In vivo natural reactivity of mice against tumor cells , 1980, International journal of cancer.
[68] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.
[69] S. Kawa,et al. Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. , 2009, Internal medicine.
[70] Sung Hoon Kim,et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment , 2008, Cancer Immunology, Immunotherapy.
[71] T. Suda,et al. Lung large cell carcinoma producing granulocyte-colony-stimulating factor. , 2007, The Annals of thoracic surgery.
[72] Heath B Acuff,et al. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. , 2006, Cancer research.
[73] L. Coussens,et al. Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.
[74] V. Morris,et al. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines , 2004, Clinical & Experimental Metastasis.
[75] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.